Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Clinical Nutrition

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3945/ajcn.2008.26362PMID 19056578PMCID PMC4340573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review article: glucagon‐like peptide 2 – current applications and future directions

  2007cited by this paper
• Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1

  2006cited by this paper
• Nutrient Control of Insulin Secretion in Isolated Normal Human Islets

  2006cited by this paper
• Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells

  2004influential reference
• Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes.

  2004cited by this paper
• Incretins, insulin secretion and Type 2 diabetes mellitus

  2004cited by this paper
• Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.

  2004cited by this paper
• Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide

  2004cited by this paper
• Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.

  2004cited by this paper
• Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.

  2004cited by this paper
• Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

  2003cited by this paper
• Oral glutamine in paediatric oncology patients: a dose finding study

  2003influential reference
• Inhibition of food intake in obese subjects by peptide YY3-36.

  2003cited by this paper
• Gut hormone PYY3-36 physiologically inhibits food intake

  2002cited by this paper
• Glutamine and the bowel.

  2001cited by this paper
• Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

  2001cited by this paper
• Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

  2001cited by this paper
• Intestinal mucosal amino acid catabolism.

  1998cited by this paper
• Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

  1998cited by this paper
• Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

  1998cited by this paper
• Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.

  1997cited by this paper
• Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.

  1995cited by this paper
• Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill.

  1994cited by this paper
• Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically III

  1994cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Glutamine and the preservation of gut integrity.

  1993cited by this paper
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

  1993cited by this paper
• Banting lecture 1990. Beta-cells in type II diabetes mellitus.

  1991cited by this paper
• β-cells in type II diabetes mellitus

  1991cited by this paper
• Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.

  1991cited by this paper
• Safety and metabolic effects of L-glutamine administration in humans.

  1990cited by this paper
• Chemotherapy

  1987cited by this paper

• Distinct gut microbiota signatures characterize glucoregulatory effects of prenatal choline and betaine in Wistar rat offspring.

  2026cites this paper
• Oral administration of l-lysine potently promotes GLP-1 secretion and lowers glycemic response in rats.

  2025cites this paper
• Physiological Fatty Acid-Stimulated Insulin Secretion and Redox Signaling Versus Lipotoxicity

  2025cites this paper
• Lactiplantibacillus plantarum strain 84-3-derived l-glutamine ameliorates glucose homeostasis via AMPK/PPARγ signaling pathway activation in type 2 diabetes.

  2025cites this paper
• Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes

  2025cites this paper
• Metabolomics Signatures of Atherosclerosis in Cardiovascular Disease: A Narrative Systematic Review

  2025cites this paper
• The Impact of Immunomodulatory Components Used in Clinical Nutrition—A Narrative Review

  2025cites this paper
• Endogenous metabolites in metabolic diseases: pathophysiological roles and therapeutic implications.

  2025cites this paper
• Modulation of the human fecal metabolome – Effect of polyphenols depends on the BMI

  2025cites this paper
• In Vitro Assessment of the Bioaccessibility and Hypoglycemic Properties of Essential Amino Acids Blend: Implication for Diabetes Management

  2025cites this paper
• Brain amino acid sensing for organismal amino acid homeostasis

  2025cites this paper
• Amino acid composition of plant protein-enriched wheat biscuits differentially affects postprandial amino acid responses of overweight/obese compared to normalweight subjects

  2025cites this paper
• Current understanding of insulin dysregulation and its relationship with carbohydrate and protein metabolism in horses.

  2025cites this paper
• Diabetes-preventive molecular mechanisms of breast versus formula feeding: new insights into the impact of milk on stem cell Wnt signaling

  2025cites this paper
• Glutamine and Its Actions: A Bird’s Eye View

  2024cites this paper
• Glutamine suppresses senescence and promotes autophagy through glycolysis inhibition-mediated AMPKα lactylation in intervertebral disc degeneration

  2024cites this paper
• Effect of Tempeh and Daidzein on Calcium Status, Calcium Transporters, and Bone Metabolism Biomarkers in Ovariectomized Rats

  2024cites this paper
• Effect of Single Oral Coingestion of GABA and Malic Acid on Postprandial GLP-1, Glucose, and Insulin Responses in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

  2024cites this paper
• l-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channels

  2024cites this paper
• Regulation of proglucagon derived peptides by carbohydrate and protein ingestion in young healthy males-A randomized, double-blind, cross-over trial.

  2024cites this paper
• Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload.

  2024cites this paper
• Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids

  2024cites this paper
• Metabolomic signatures of ideal cardiovascular health in black adults

  2024cites this paper
• Dipeptide alanine-glutamine ameliorates retinal neurodegeneration in an STZ-induced rat model

  2024cites this paper
• Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment

  2024cites this paper
• Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions – a narrative review

  2024influential citation
• Metabolic hormones are integral regulators of female reproductive health and function

  2023cites this paper
• Metabolome-wide association study on physical activity

  2023cites this paper
• Microbial dietary protein metabolism regulates GLP‐1 mediated intestinal transit

  2023cites this paper
• Glutamine Ameliorates Liver Steatosis via Regulation of Glycolipid Metabolism and Gut Microbiota in High-Fat Diet-Induced Obese Mice.

  2023cites this paper
• Recent advances on the biological activities of purple sweet potato anthocyanins

  2023cites this paper
• Synergistic enhancement of glucagon-like peptide-1 release by γ-aminobutyric acid and L-phenylalanine in enteroendocrine cells - searching active ingredients in a water extract of Corn Zein protein.

  2023cites this paper
• Effects of Ingesting Amino Acids Simultaneously with Glucose and Fat on Postchallenge Metabolism in Healthy Young Women

  2023cites this paper
• Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study

  2023cites this paper
• Glutamine production by Glul promotes thermogenic adipocyte differentiation through Prdm9-mediated H3K4me3 and transcriptional reprogramming.

  2023cites this paper
• GLP-1 - Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy.

  2022cites this paper
• The molecular determinants of glucagon-like peptide secretion by the intestinal L-cell.

  2022cites this paper
• Beneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia

  2022cites this paper
• Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease

  2022cites this paper
• Effects of Co-ingestion of Amino Acids with Fat on Postchallenge Glycemia and Lipidemia in Healthy Young Women

  2022cites this paper
• Obesity-Related Adipose Tissue Remodeling in the Light of Extracellular Mitochondria Transfer

  2022cites this paper
• A comprehensive review on the glucoregulatory properties of food-derived bioactive peptides

  2022cites this paper
• The potential antidiabetic properties of Liang (Gnetum gnemon var.tenerum) leaves

  2022cites this paper
• The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes

  2022cites this paper
• Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity—A systematic review and meta‐analysis

  2022cites this paper
• Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies.

  2022cites this paper
• The association of dietary glutamine supplementation with the development of high salt-induced hypertension in rats

  2022cites this paper
• Targeting the Enteroendocrine System for Treatment of Obesity.

  2022cites this paper
• Colonic Delivery of Nutrients for Sustained and Prolonged Release of Gut Peptides: A Novel Strategy for Appetite Management

  2022cites this paper
• A review on mechanisms of action of bioactive peptides against glucose intolerance and insulin resistance

  2022cites this paper
• The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion

  2022cites this paper
• Glucose-Dependent Insulinotropic Polypeptide-A Postprandial Hormone with Unharnessed Metabolic Potential.

  2022cites this paper
• The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion

  2021cites this paper
• Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response

  2021cites this paper
• Proglucagon-Derived Peptides as Therapeutics

  2021cites this paper
• Childhood overeating is associated with adverse cardiometabolic and inflammatory profiles in adolescence

  2021cites this paper
• Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy.

  2021cites this paper
• Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis

  2021cites this paper
• Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity

  2021cites this paper
• Repurposing statin and L-glutamine: replenishing β-cells in hyperlipidemic T2D mouse model

  2021cites this paper
• Glucagon-like peptide-1 regulation by food proteins and protein hydrolysates

  2021cites this paper
• Messages from the Small Intestine Carried by Extracellular Vesicles in Prediabetes: A Proteomic Portrait

  2021cites this paper
• Amino acids differ in their capacity to stimulate GLP-1 release from the perfused rat small intestine and stimulate secretion by different sensing mechanisms.

  2021cites this paper
• Chemosensing in enteroendocrine cells: mechanisms and therapeutic opportunities.

  2021cites this paper
• Plasma amino acid profile, a biomarker for visceral adipose tissue that can substitute for waist circumference in Japanese Americans.

  2021cites this paper
• Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case–control study nested within the French E3N cohort

  2021cites this paper
• Glutamine metabolism in adipocytes: a bona fide epigenetic modulator of inflammation

  2020cites this paper
• What Is GLP-1 Really Doing in Obesity?

  2020cites this paper
• Circulating glucagon-like peptide-1 level in patients with liver cirrhosis

  2020cites this paper
• Effects of Anthocyanin Extracts from Bilberry (Vaccinium myrtillus L.) and Purple Potato (Solanum tuberosum L. var. ‘Synkeä Sakari’) on the Plasma Metabolomic Profile of Zucker Diabetic Fatty Rats

  2020cites this paper
• Targeting Glutamine Synthesis Inhibits Stem Cell Adipogenesis in Vitro.

  2020cites this paper
• Postprandial glycemia and insulin secretion following glutamine administration: A randomized controlled trial.

  2020cites this paper
• The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview

  2020influential citation
• Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes

  2020cites this paper
• A comprehensive insight into the effect of glutamine supplementation on metabolic variables in diabetes mellitus: a systematic review

  2020influential citation
• A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study

  2020cites this paper
• Gut microbiota-derived metabolites in obesity: a systematic review

  2020cites this paper
• L-glutamine for sickle cell disease: Knight or pawn?

  2020cites this paper
• Glutamine and its antioxidative potentials in diabetes

  2020cites this paper
• A metabolomic approach to identify the link between sports activity and atheroprotection.

  2020cites this paper
• DIETARY FACTORS AFFECTING FIRMICUTES AND BACTEROIDETES RATIO IN SOLVING OBESITY PROBLEM: A LITERATURE REVIEW

  2020cites this paper
• Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort

  2020cites this paper
• Pre-proofs Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro

  2019cites this paper
• Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications.

  2019cites this paper
• Does glutamine supplementation have favorable effects on glucose control and insulin sensitivity?

  2019cites this paper
• Glucagon-like peptide 1 (GLP-1)

  2019cites this paper
• Metabolome-wide Association Study with Habitual Physical Activity in Four Prospective Cohort Studies.

  2019cites this paper
• High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial.

  2019cites this paper
• Modulation of Hormonal, Oxidative Stress and Fatty Acids Profiling in Response to Glutamine and Chromium in Diabetic Rats

  2019influential citation
• Effect of Oyster Meat Preload on Postmeal Glycemic Control in Healthy Young Adults

  2019cites this paper
• Glutamine deprivation induces metabolic adaptations associated with beta cell dysfunction and exacerbate lipotoxicity.

  2019cites this paper
• Peptone‐mediated glucagon‐like peptide‐1 secretion depends on intestinal absorption and activation of basolaterally located Calcium‐Sensing Receptors

  2019cites this paper
• Study on Hypoglycemic Effect of the Drug Pair of Astragalus Radix and Dioscoreae Rhizoma in T2DM Rats by Network Pharmacology and Metabonomics

  2019cites this paper
• The Emerging Role of l-Glutamine in Cardiovascular Health and Disease

  2019cites this paper
• Targeting the Enteric Nervous System to Treat Metabolic Disorders? “Enterosynes” as Therapeutic Gut Factors

  2019cites this paper
• Original Contribution Metabolome-Wide Association Study of the Relationship Between Habitual Physical Activity and PlasmaMetabolite Levels

  2019cites this paper
• Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro.

  2019cites this paper
• Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes

  2019cites this paper
• Role of Melatonin, Glutamine and L-arginine in Prevention of Non-alcoholic Fatty Liver Disease in Rats

  2019cites this paper